As more and more people suffer from obesity and,
consequently, obesity-related diseases, scientists are faced with a new question:
is there a pill that can fight obesity? Doctors have long recommended overweight
and obese people have an active life and a healthy diet based mainly on
vegetables and fruits, but what if they can’t comply with the requests. We all
know that it’s easier to swallow a pill and wait for the miracles of science to
happen. Is that wrong, is that good? I guess everybody needs to answer on its
own, but I think a combination of pills and healthy habits would be certainly
of more help in the case of obese people.
When it comes to anti-obesity pills, there are few choices
on the market and no one can guarantee you they will really work. But US
scientists have now identified a fatty substance that exists naturally in our
body which blocks hunger and weight gain. Mice and rats, and presumably humans,
produce the chemical after eating a fatty meal.
German Shulman, an investigator at the Howard Hughes Medical
Institute and a professor of internal medicine and of cellular and molecular
physiology at Yale University School of Medicine, gave mice an extra dose of
this chemical, called N-acylphosphatidylethanolamine (NAPE) and found that they
ate less and shed weight, with no side effects. Tests will have to be made on
larger animals, but if they turn out to be well, humans might be next.
“We’re excited but we have to be cautious. We would love to be
able to take this to man tomorrow because we need effective ways to treat
obesity and, right now, we have very few agents that work effectively. But we
have much work to do,” Shulman said. He and his colleagues are well known for
their work on understanding how insulin resistance develops and leads to
diabetes.
In this study, rats were given NAPE for five days and there
was a continuous reduction in food intake and a decline in body weight. To be
more explicit, they ate 30 percent less food and lost a quarter of their
weight. “It suggests NAPE or long-acting NAPE analogs may treat obesity,”
Shulman said.
The study is the first of its kind. It clearly showed that
injecting NAPE into the rats’ bloodstream lowered their food consumption
without making food unappealing to them. The study also found a connection
between injecting NAPE directly into the rats’ brain and a drop in calorie
consumption.
If these findings apply to humans too, they will be a
salvation for the 300 million adults who suffer from obesity worldwide and who
are at high risk for life-threatening illnesses such as type 2 diabetes, cardiovascular
disease, cancer, all consequences of obesity.
“We have this epidemic of obesity and we have very few
agents that are able to effectively treat obesity. We’d be quite interested in
trying a clinical trial to see if giving back would reduce food intake in
humans,” Shulman said.